Title of article
Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA—II. Modification of pyrrolidine ring at P1′ proline Original Research Article
Author/Authors
Tomoaki Komai، نويسنده , , Susumu Higashida، نويسنده , , Mitsuya Sakurai، نويسنده , , Tamayo Nitta، نويسنده , , Atsushi Kasuya، نويسنده , , Shuichi Miyamaoto، نويسنده , , Ryuichi Yagi، نويسنده , , Yuji Ozawa، نويسنده , , Hiroshi Handa، نويسنده , , Hiroshi Mohri، نويسنده , , Akira Yasuoka، نويسنده , , Shinichi Oka، نويسنده , , Takashi Nishigaki، نويسنده , , Satoshi Kimura، نويسنده , , Kaoru Shimada، نويسنده , , Yuichiro Yabe، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1996
Pages
13
From page
1365
To page
1377
Abstract
Systematic replacement in the 3- or 4-position of the pyrrolidine ring at P1′ proline was carried out. Compound 26, which has a Cl atom in the 4(S)-position was the most active among inhibitors substituted with other halogen atoms or other substituents. Furthermore, the replacement of the Z group in compound 26 with five- or six-membered fused aromatic heterocycle carbonyl groups produced more potent inhibitors. 7-Methoxybenzofuran-2-carbonyl derivative (44) was the best of these and showed Ki = 4.5 nM against HIV PR and IC90s 0.58 μM and 0.06 μM in chronic and acute infections, respectively. These results suggest that the combination of the 4(S)-Cl atom and fused bicyclic heterocycles may be effective in improving their cellular penetration.
Journal title
Bioorganic and Medicinal Chemistry
Serial Year
1996
Journal title
Bioorganic and Medicinal Chemistry
Record number
1300894
Link To Document